Press releases
Access archived Guidant press releases
Access archived BTG press releases
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
-
Dec 31, 2005
(February 7, 2006) -- Boston Scientific Corporation (NYSE: BSX) today announced financial results for the year and fourth quarter ended December 31, 2005. 2005 HIGHLIGHTS Net sales of $6.283...
-
Dec 21, 2005
(December 21, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced it has made a $250,000 gift to Doctors Without Borders, an international medical humanitarian organization, in...
-
Dec 14, 2005
(December 14, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced a $500,000 contribution to the University of Minnesota Foundation to fund the creation of a Boston Scientific...
-
Dec 8, 2005
(December 8, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced that it is voluntarily recalling all Flextome Cutting Balloon
-
Dec 8, 2005
(December 8, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced that it has been recognized with the American Red Cross
-
Dec 6, 2005
(December 6, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced that two of its senior executives are scheduled to participate in the first annual Massachusetts Conference for...
-
Dec 5, 2005
(December 5, 2005)
-
Nov 23, 2005
(November 23, 2005) -- Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in The Fifth Annual Merrill Lynch Med Tech Fundamentals Conference, which is being held on Thursday,...
-
Nov 17, 2005
(November 17, 2005) -- Boston Scientific Corporation (NYSE: BSX) announced today the completion of a public offering of $750 million aggregate principal amount of its senior notes under the Company
-
Nov 14, 2005
(November 14, 2005) -- Boston Scientific Corporation (NYSE: BSX) announced today the pricing of a public offering of $750 million aggregate principal amount of its senior notes under the Company
-
Nov 10, 2005
(November 10, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced that it has received approval from the U.S. Food and Drug Administration (FDA) to begin a prospective, randomized,...
-
Nov 8, 2005
and Vancouver, B.C. (November 8, 2005) -- Boston Scientific Corporation (NYSE: BSX) and Angiotech Pharmaceuticals, Inc. (NASDAQ: ANPI; TSX: ANP) announced today that they have jointly received the...
-
Nov 1, 2005
(November 1, 2005) -- Boston Scientific Corporation (NYSE: BSX) announced today that the Centers for Medicare and Medicaid Services (CMS) has approved its application for a new series of...
-
Oct 31, 2005
(October 31, 2005) -- Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the CIBC World Markets Sixteenth Annual Healthcare Conference, which is being held November 7-9 in...
-
Oct 25, 2005
(October 25, 2005)
-
Oct 24, 2005
(October 24, 2005) -- Boston Scientific Corporation (NYSE: BSX) announced today that it has acquired a portfolio of proprietary endoscopic stent technologies from Willy Rüsch GmbH (Rüsch), a...
-
Oct 20, 2005
and Washington, D.C. (October 20, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced 30-day safety data from the transitional phase of its OLYMPIA registry. The OLYMPIA registry is...
-
Oct 20, 2005
and Washington, D.C. (October 20, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced nine-month sub-population data from its TAXUS V clinical trial that further supports the...
-
Oct 19, 2005
and Washington, D.C. (October 19, 2005) -- Boston Scientific Corporation (NYSE: BSX) was recognized by physicians as a leader in the pursuit of evidence-based medicine through increased use of...
-
Oct 18, 2005
and Washington, D.C. (October 18, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced follow-up data supporting excellent long-term safety and efficacy from four of its TAXUS...
-
Oct 17, 2005
(October, 17, 2005) -- Boston Scientific Corporation (NYSE: BSX) today presented data from its BEACH clinical trial, which was designed to evaluate the benefits of carotid artery stenting (CAS) in...
-
Oct 17, 2005
, and Washington, D.C. (October 17, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced the combined results from the BLAZE and BLAZE II registries showing that its...
-
Oct 14, 2005
(October 14, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced financial results for its third quarter ended September 30, 2005 and provided revised revenue and earnings-per-share...
-
Oct 13, 2005
(October 13, 2005) -- Boston Scientific Corporation (NYSE: BSX) today introduced a new program that will offer participating medical centers in the United States a TAXUS® Express2™ stent system...